![]() BioAtla BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer. | ![]() DAVA Oncology DAVA Oncology is a company that provides solutions and services to the pharmaceutical and biotechnology industries aiming to support cancer drug development. | Orionis Biosciences Orionis Biosciences is a company that specializes in drug discovery and development with a focus on oncology and immunotherapies. | |||
Founding Date | Founding Date 2007 | Founding Date 2007 | Founding Date 2001 | Founding Date 2015 | Founding Date 1998 |
Type | Type Public | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Dallas, US HQ | Locations Lund, SE HQ | Locations Waltham, US HQ Gent, BE | Locations Seongnam-si, KR HQ |
Employees | Employees 616% decrease | Employees 823% increase | Employees 1555% decrease | Employees 52 | Employees 50 |
Valuation ($) | Valuation ($) 100.8 m | Valuation ($) N/A | Valuation ($) 59 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr514k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₩99.8b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ₩438.8m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit kr1.1m (FY, 2025) | Gross profit N/A | Gross profit ₩100b (FY, 2025) |
Net income | Net income ($59.6m) (FY, 2025) | Net income N/A | Net income (kr51.4m) (FY, 2025) | Net income N/A | Net income ₩54.4b (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 186.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 23.7m | Total funding raised N/A |

DAVA Oncology is a company that provides solutions and services to the pharmaceutical and biotechnology industries aiming to support cancer drug development.
View company
Alligator develops antibody-based pharmaceuticals for cancer treatment.
View companyOrionis Biosciences is a company that specializes in drug discovery and development with a focus on oncology and immunotherapies.
View company
Oscotec is a clinical stage drug discovery and development company.
View company